The Role of Platelets in Athero-Thrombotic Events

Author(s): Matthias K. Freynhofer, Veronika Bruno, Johann Wojta, Kurt Huber

Journal Name: Current Pharmaceutical Design

Volume 18 , Issue 33 , 2012

Become EABM
Become Reviewer
Call for Editor


The crucial role of platelets in primary hemostasis and repair of injured endothelium is well established, as is their role in atherothrombosis. No other single cell type is responsible for as much morbidity and mortality, since death from ischemic heart disease or stroke is by far the leading cause of death worldwide. There is no doubt that our understanding of atherothrombosis has guided current antithrombotic strategies that have dramatically reduced ischemic complications and cardiovascular mortality within the last decades. Yet the rate of ischemic complications after optimal revascularization therapy remains disappointingly high. There is still a strong need for new and smart antiplatelet drugs. The ideal antithrombotic drug would spare physiological platelet function, hemostasis and vascular repair in order to avoid bleeding complications, but would exclusively target the pathological atherothrombotic process. As platelet activity might be determined early in the bone marrow, this review starts with insights into the birth of platelets, describes the essential and primary role of platelets in hemostasis with new evidence in signaling cascades, and closes with the deleterious role of platelets in atherosclerosis and atherothrombosis, with a focus on acute coronary syndromes.

Keywords: Platelets, atherothrombosis, hemostasis, acute coronary syndromes

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 24 September, 2012
Page: [5197 - 5214]
Pages: 18
DOI: 10.2174/138161212803251899

Article Metrics

PDF: 68